Forms and strengths
- 0.045% lotion (Rx)
- 0.05% and 0.1% cream and gel (Rx, generic)
- 0.1% foam (Rx)
How to use it
Thin layer at night on dry skin, starting every other night; many people need a moisturizer buffer for the first month. Short-contact application (rinse after 20–60 minutes) is a recognized tolerability strategy.
Side effects and cautions
- Burning, stinging, and peeling
- Dryness and redness
- Photosensitivity
Contraindicated in pregnancy; the label advises a pregnancy test before starting in people who can become pregnant. Avoid on eczematous skin and with other drying agents until tolerated.
Regulatory status
FDA-approved prescription drug for acne, psoriasis, and (0.1% cream) facial photodamage. Prescription-only in the U.S., U.K., E.U., and Canada.
In the trends
Tazarotene is having a moment on social media as the 'strongest retinoid'; strength without tolerance produces quitting, not results.
Sources on file
These links support the claims above. Reviewed September 1, 2026. Drug labels link to DailyMed searches so the current label is always one click away.
- NIH DailyMed — tazarotene labels (opens in a new tab)
- J Am Acad Dermatol 2000 — tazarotene versus tretinoin or adapalene in acne (PubMed) (opens in a new tab)
- Cutis 2001 — tazarotene 0.1% gel versus tretinoin 0.025% gel in facial acne: randomized trial (PubMed) (opens in a new tab)
- J Am Acad Dermatol 2005 — tazarotene 0.1% cream for photodamage: randomized trial (PubMed) (opens in a new tab)
- Arch Dermatol 2001 — tazarotene creams versus tretinoin 0.05% for facial photodamage (PubMed) (opens in a new tab)
- American Academy of Dermatology — 2024 acne guideline (opens in a new tab)